CD26 has a cleavage activity against diverse substrates such as chemokines, such as disruption of the SDF1-CXCR4 axis leading to the release of CML LSCs into the PB [16]. This evidence concerns the gene DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive.